PREZCOBIX

Product Overview

About PREZCOBIX

PREZCOBIX is a prescription medication containing the active ingredients COBICISTAT and DARUNAVIR (DARUNAVIR ETHANOLATE). It is used in combination with other antiretroviral medications to treat HIV-1 infection in adults and pediatric patients 12 years of age and older.

Key Benefits & Uses

• Treatment of HIV-1 infection in combination with other antiretroviral medications.
• Reduces the viral load and increases the CD4 cell count in patients with HIV-1 infection.
• Used in combination with other medications to prevent HIV-1 infection in adults and pediatric patients 12 years of age and older.

Active Ingredient & Action

COBICISTAT is a CYP3A inhibitor that increases the plasma concentrations of DARUNAVIR, a potent HIV protease inhibitor. DARUNAVIR (DARUNAVIR ETHANOLATE) works by inhibiting the protease enzyme, which is essential for the replication of HIV-1 virus. By inhibiting the protease enzyme, DARUNAVIR prevents the virus from replicating and reduces the viral load in the body.

Important Notes

PREZCOBIX should be used under the guidance of a healthcare professional. It is essential to follow the prescribed dosage and treatment regimen to achieve optimal results. Patients with pre-existing medical conditions, such as liver or kidney disease, should consult their healthcare provider before taking PREZCOBIX. Common side effects include nausea, diarrhea, and fatigue. Patients should report any adverse reactions to their healthcare provider promptly.